Wednesday, July 8, 2026
🇺🇸 FDA

biotech · FBIO

Fortress Biotech

NovaPharmaNews editorial coverage mentioning Fortress Biotech — regulatory, clinical, and market analysis.

BAY HARBOR ISLANDS, FL, USA HQ
Public company Type
FBIO · NYSE Ticker
Company details
Status
Public
HQ
BAY HARBOR ISLANDS, FL, USA
Programs
0
Drugs
0
Patents
1
Patents News & analysis

Recent coverage

View all news & analysis →
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Fortress Biotech — regulatory, clinical, and market coverage.

NovaPharmaNews editorial coverage mentioning Fortress Biotech — regulatory, clinical, and market analysis.

All News Analysis

1 articles

Big Pharma's Shift to Smaller Deals Boosts Biotech Sector
High impact NewsJun 2, 2026

Big Pharma's Shift to Smaller Deals Boosts Biotech Sector

6 min

Big Pharma is strategically shifting its M&A focus from mega-deals to more disciplined, mid-sized acquisitions. This trend is proving to be a significant boon for the biotech sector, offering new avenues for growth and investment.

Dr. Sarah Mitchell

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.